FACT-Br for assessment of quality of life in patients receiving treatment for brain metastases: A literature review

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 11, Issue 6, 2011, Pages 701-708

  Lien, Karen ^a   Zeng, Liang ^a   Nguyen, Janet ^a   Cramarossa, Gemma ^a   Cella, David ^b   Chang, Eric ^c   Caissie, Amanda ^a   Holden, Lori ^a   Culleton, Shaelyn ^a   Sahgal, Arjun ^a   Chow, Edward ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

brain metastases; FACT Br; quality of life assessment tools

Indexed keywords

CAPECITABINE; DEXMETHYLPHENIDATE; DONEPEZIL; GADOLINIUM TEXAPHYRIN; GEFITINIB; PLACEBO; TEMOZOLOMIDE;

BRACHYTHERAPY; BRAIN METASTASIS; CANCER PALLIATIVE THERAPY; CHEMORADIOTHERAPY; FUNCTIONAL ASSESSMENT OF CANCER THERAPY BRAIN; HUMAN; NEUROPSYCHOLOGICAL TEST; PATIENT COMPLIANCE; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SENSITIVITY AND SPECIFICITY; STEREOTACTIC RADIOSURGERY;

BRAIN NEOPLASMS; HUMANS; NEUROPSYCHOLOGICAL TESTS; PALLIATIVE CARE; PREDICTIVE VALUE OF TESTS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME;

EID: 81755177527     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/erp.11.67     Document Type: Review

References (30)

1. Loeffler JS, Patchell RA, Sawaya R. Treatment of metastatic cancer. In Cancer: Principles and Practice of Oncology (5th Edition). Devita VT, Hellman S, Rosenburg SA (Eds). Lippincott-Raven Publishers, PA, USA, 2523-2536 (1997).
2. Mor V, Laliberte L, Morris JN et al. The Karnofsky performance status scale: an examination of its reliability and validity in a research setting. Cancer 53(9), 2002-2007 (1984).
3. Cella DF, Tulsky DS, Gray G et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J. Clin. Oncol. 11(3), 570-579 (1993).
4. Weitzner MA, Meyers CA, Gelke CK et al. The functional assessment of cancer therapy (FACT) scale: development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer 75(5), 1151-1161 (1995).
5. Mehta MP, Rodrigus P, Terhaard CH et al. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J. Clin. Oncol. 21(13), 2529-2536 (2003).
6. Rivera E, Meyers C, Groves M et al. Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma. Cancer 107(6), 1348-1354 (2006).
7. Rogers LR, Rock JP, Sills AK et al. Results of a Phase II trial of the GliaSite radiation therapy system for the treatment of newly diagnosed, resected single brain metastases. J. Neurosurg. 105(3), 375-384 (2006).
8. Shaw EG, Rosdhal R, D'Agostino RB Jr et al. Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J. Clin. Oncol. 24(9), 1415-1420 (2006).
9. Addeo R, Caraglia M, Faiola V et al. Concomitant treatment of brain metastasis with whole brain radiotherapy [WBRT] and temozolomide [TMZ] is active and improves quality of life. BMC Cancer 25, 18 (2007).
10. Butler JM Jr, Case LD, Atkins J et al. A Phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo- methylphenidate HCl in brain tumor patients receiving radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 69(5), 1496-1501 (2007).
11. Chang EL, Wefel JS, Maor MH et al. A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone. Neurosurgery 60(2), 277-283 (2007).
12. Doyle M, Bradley NM, Li K et al. Quality of life in patients with brain metastases treated with a palliative course of whole-brain radiotherapy. J. Palliat. Med. 10(2), 367-374 (2007).
13. Li J, Bentzen SM, Li J et al. Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis. Int. J. Radiat. Oncol. Biol. Phys. 71(1), 64-70 (2008).
14. Chang EL, Wefel JS, Hess KR et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 10(11), 1037-1044 (2009).
15. Ma S, Xu Y, Deng Q et al. Treatment of brain metastasis from non-small cell lung cancer with whole brain radiotherapy and gefitinib in a Chinese population. Lung Cancer 65(2), 198-203 (2009).
16. Kelsey CR, Mukundan S Jr, Wang Z et al. Assessing neurotoxicity from the low-dose radiation component of radiosurgery using magnetic resonance spectroscopy. Neuro. Oncol. 12(2), 145-152 (2010).
17. Walter J, Kuhn SA, Waschke A et al. Operative treatment of subcortical metastatic tumours in the central region. J. Neurooncol. 103(3), 567-573 (2010).
18. Hashem T, Kamal-Eldin K, Metwaly H et al. Prophylactic cranial irradiation (PCI) in high-risk breast cancer patients: preliminary data. J. Clin. Oncol. 26, Abstract 11501 (2008).
19. Bradley N, Davis L, Chow E. Symptom distress in patients attending an outpatient palliative radiotherapy clinic. J. Pain Symptom Manage. 30(2), 123-131 (2005).
20. Bezjak A, Adam J, Barton R et al. Symptom response after palliative radiotherapy for patients with brain metastases. Eur. J. Cancer 38(4), 487-496 (2002).
21. Zeng L, Sahgal A, Zhang L et al. Patterns of pain and functional improvement in patients with bone metastases after conventional external beam radiotherapy and a telephone validation study. Pain Res. Treat. 1-9 (2011).
22. Steinmann D, Schafer C, van Oorschot B et al. Effects of radiotherapy for brain metastases on quality of life (QoL). Prospective pilot study of the DEGRO QoL working party. Strahlenther. Onkol. 185(3), 190-197 (2009).
23. Lee H, Friedman ME, Cukor P et al. Interactive voice response system (IVRS) in health care services. Nurs. Outlook 51(6), 277-283 (2003).
24. Blondin JM, Abu-Hasaballah KS, Tennen H et al. Electronic versus paper diaries: a pilot study of concordance and adherence in head and neck cancer patients receiving radiation therapy. Head Neck Oncol. 2, 29 (2010).
25. Agel J, Rockwood T, Mundt JC et al. Comparison of interactive voice response and written self-administered patient surveys for clinical research. Orthopedics 24(12), 1155-1157 (2001).
26. Giesinger JM, Golser M, Erharter A et al. Do neurooncological patients and their significant others agree on quality of life ratings? Health Qual. Life Outcomes 9(7), 87 (2009).
27. Brown PD, Decker PA, Rummans TA et al. A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: comparison of patient and caregiver ratings of quality of life. Am. J. Clin. Oncol. 31(2), 163-168 (2008).
28. Moinpour CM, Lyons B, Schmidt SP et al. Substituting proxy ratings for patient ratings in cancer clinical trials: an analysis based on a Southwest Oncology Group trial in patients with brain metastases. Qual. Life Res. 9(2), 219-231 (2000).
29. Meyers CA, Smith JA, Bezjak A et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized Phase III trial. J. Clin. Oncol. 22(1), 157-165 (2004).
30. Giovagnoli AR, Boiardi A. Cognitive impairment and quality of life in long-term survivors of malignant brain tumors. Ital. J. Neurol. Sci. 15(9), 481-488 (1994).